Strides Pharma Science Ltd
STAR price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- STAR
- MB Code
- MBEQU252
- ISIN
- INE939A01011
- BSE code
- 532531
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 1323.47 Cr
- Net profit
- 129.28 Cr
- EPS
- 13.77
- YoY revenue
- +11.18%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for STAR
Strides Pharma kept its $375-400 million North America FY28 target, expects US recovery from H2FY27, and reported Q4 profit up 51% YoY to…
Strides Pharma Science reported Q4 FY26 net profit up 51% to Rs 129.28 crore, with revenue at Rs 1,323.47 crore; board recommended a fina…
Strides Pharma Science Ltd reported a significant increase in Q3 net profit to Rs 208.12 crore for the quarter ending December 31, 2025, …
Strides Pharma's stock surged 10% on January 30, 2026, following a strong Q3 report, with a net profit increase to ₹202 crore and a reven…
Strides Pharma shares surged 10% to an all-time high of ₹1,025 on November 3, 2025, driven by strong trading volumes and a positive outlo…
Strides Pharma's stock surged 15% to an all-time high following a strong Q2 earnings report, highlighting an expanded product portfolio a…
Strides Pharma's Q2 results showed a 13% stock surge on October 31, 2025, driven by an 82% net profit increase to ₹131.5 crore and a 25.4…
Dividend of ₹4.00 per share
Ex-date corporate action
Price returns
Historical performance
Technicals
Indicator consensus